10月8日，新锐医药(06108)盘中下跌20.25%，截至13:54，报0.063元/股，成交107.5万元。
新锐医药国际控股有限公司是一家在中国，尤其是浙江省，主营医药分销业务的公司，涵盖从获取分销权、市场研发新产品，到供应商合作、产品采购、销售、营销及存储和运输等环节。公司的大部分产品由分销商客户按照区域独占条款分销至全国范围的医院和医疗机构，其分销的所有医药产品都为仿制医药产品。
截至2024年中报，新锐医药营业总收入1525.82万元、净利润-373.1万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.